Access to Meilahti Emergency Department is via the Bridge Hospital entrance (Paciuksenkatu 3) starting January 8, 2024
5.1.2024 05:55:00 EET | HUS | Press release
The access route for patients arriving independently to the Meilahti Emergency Department changes on January 8, 2024, at 7:15 am. Access to the emergency department is only via the Bridge Hospital entrance (Paciuksenkatu 3). It will no longer be possible to enter the emergency department via the Haartman Hospital entrance. This applies to all patients arriving independently with or without a doctor's referral.

Registration and assessment of treatment needs will take place in the emergency department's entrance lobby from where patients are directed to treatment.
The entrances for patients arriving by ambulance will not change.
The Meilahti Emergency Department treats primary healthcare and specialized healthcare patients.
For primary healthcare, the Meilahti Emergency Department mainly serves residents over the age of 16 from southern, central and western Helsinki who need urgent care when their local health center is closed. Service hours are 4:00–10:00 p.m. on weekdays, and 8:00a.m.–10:00p.m. on weekends and public holidays.
For specialized healthcare, the Meilahti Emergency Department serves the entire HUS region as the 24/7 emergency department for specialized healthcare where patients usually arrive by ambulance or doctor’s referral.
Before seeking medical attention at the emergency department
We recommend calling the Medical Helpline 116 117. The Medical Helpline will direct you to the correct place of care and give you care instructions as necessary. In an emergency, always call 112 directly.
Contacts
Timo Suonsyrjä
Head Physician, Meilahti Emergency Department
timo.suonsyrja@hus.fi
050 427 0829
Images
About HUS
HUS Helsinki University Hospital is the biggest provider of specialized healthcare in Finland. Our high expertise is internationally recognized and accredited. As a university hospital, we are on the cutting edge of developing and evaluating our treatment methods and activities.
HUS treats almost 700,000 patients every year. Our nearly 27,000 professionals work to provide the best possible care for our patients. We are responsible for organizing specialized health care in the Uusimaa region. The treatment of many rare and difficult diseases in Finland has been centralized to HUS as well.
HUS – Leading healthcare
Alternative languages
Subscribe to releases from HUS
Subscribe to all the latest releases from HUS by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from HUS
Arbetet för babyvänlig verksamhet fortsätter – utvecklingsarbetet fortsätter med ny sammansättning2.7.2026 10:28:59 EEST | Pressmeddelande
Efter att Institutet för hälsa och välfärd THL:s nationella samordnande upphörde fortsätter arbetet för babyvänlig verksamhet i samarbete med alla välfärdsområden. Målet för den sakkunniggrupp som HUS har sammankallat är att trygga och utveckla babyvänlig vård i hela landet.
Vauvamyönteinen työ jatkuu – kehittämistyö jatkuu uudella kokoonpanolla2.7.2026 10:28:59 EEST | Tiedote
THL:n kansallisen koordinaation päätyttyä vauvamyönteisyystyö jatkuu yhteistyössä kaikkien hyvinvointialueiden kanssa. HUSin koollekutsuman asiantuntijaryhmän tavoitteena on turvata ja kehittää vauvamyönteistä hoitoa koko maassa.
Blodprov underlättar diagnostiken av lymfkörtelinflammationer i halsområdet hos barn1.7.2026 08:54:42 EEST | Pressmeddelande
En studie som genomförts vid HUS har bekräftat tillförlitligheten hos en blodprovsbaserad diagnostisk metod för lymfkörtelinflammationer i halsområdet hos barn som orsakas av miljömykobakterier. Ett blodprov är ett snabbare och för patienten mer skonsamt sätt att säkerställa diagnosen än invasiva metoder, såsom vävnadsprovtagning.
Verikoe helpottaa lasten kaulan alueen imusolmuketulehdusten diagnostiikkaa1.7.2026 08:54:42 EEST | Tiedote
HUSissa tehdyssä tutkimuksessa todennettiin verikokeeseen perustuvan diagnostisen menetelmän luotettavuus ympäristömykobakteerien aiheuttamissa lasten kaulan alueen imusolmuketulehduksissa. Verikoe on nopeampi ja potilaalle miellyttävämpi tapa varmistaa diagnoosi kuin kajoavat menetelmät, kuten koepalan otto.
A blood test aids the diagnosis of cervical lymphadenitis in children1.7.2026 08:54:42 EEST | Press release
A study conducted at HUS confirmed the reliability of a blood test-based method for diagnosing cervical lymphadenitis caused by nontuberculous mycobacteria (NTM) in children. A blood test is a faster and more comfortable way to confirm a diagnosis than invasive procedures, such as a biopsy.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom

